Therapure Biopharma, Inc. v. DynPort Vaccine Company LLC
| THERAPURE BIOPHARMA, INC. |
| DYNPORT VACCINE COMPANY LLC |
| 22-1763 |
| July 19, 2022 |
| U.S. Court of Appeals, Fourth Circuit |
| Other Contract Actions |
Docket Report
RSS Track this Docket
This docket was last retrieved on August 2, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 13 DOCKETING STATEMENT by DynPort Vaccine Company LLC.. [1001204820] [22-1763] Matthew Hellman [Entered: 08/02/2022 01:04 PM] |
Filing 12
ORDER filed granting Motion to extend filing time [ # 11 ]. Number of days granted: 60. Opening brief and appendix due 10/28/2022. Opening/Response Brief Due: 12/05/2022. Response/Reply Brief Due 01/11/2023. No paper copies required unless case has been tentatively calendared or copies otherwise ordered. Copies to all parties. [1001203116] [22-1722, 22-1763] TB [Entered: 07/29/2022 02:59 PM]
|
| Filing 11 Joint MOTION by Therapure Biopharma, Inc. in 22-1722, 22-1763 to extend filing time for JOINT MOTION FOR EXTENSION OF DEADLINES until Oct. 3, 2022 for the Scheduled Mediation, Oct. 28, 2022 for the Opening Brief, Dec. 5, 2022 for the Opening/Response Brief, and Jan. 11, 2023 for the Response/Reply Brief.. Date and method of service: 07/29/2022 ecf. [1001202958] [22-1722, 22-1763] Lora Brzezynski [Entered: 07/29/2022 12:49 PM] |
| Filing 10 Initial mediation conference scheduled. [1001199576] [22-1722, 22-1763] LHP [Entered: 07/25/2022 12:56 PM] |
| Filing 9 APPEARANCE OF COUNSEL by Jessica C.Abrahams for Therapure Biopharma, Inc. in 22-1722, 22-1763. [1001199096] [22-1722, 22-1763] Jessica Abrahams [Entered: 07/22/2022 05:35 PM] |
| Filing 8 DISCLOSURE STATEMENT by Therapure Biopharma, Inc. in 22-1722, 22-1763. Was any question on Disclosure Form answered yes? Yes [1001199095] [22-1722, 22-1763] Lora Brzezynski [Entered: 07/22/2022 05:32 PM] |
| Filing 7 APPEARANCE OF COUNSEL by Lora A. Brzezynski for Therapure Biopharma, Inc. in 22-1722, 22-1763. [1001199089] [22-1722, 22-1763] Lora Brzezynski [Entered: 07/22/2022 05:06 PM] |
| Filing 6 DISCLOSURE STATEMENT by DynPort Vaccine Company LLC in 22-1722, 22-1763. Was any question on Disclosure Form answered yes? Yes [1001198895] [22-1722, 22-1763] Matthew Hellman [Entered: 07/22/2022 03:07 PM] |
| Filing 5 APPEARANCE OF COUNSEL by Matthew S. Hellman for DynPort Vaccine Company LLC in 22-1722, 22-1763. [1001197035] [22-1722, 22-1763] Matthew Hellman [Entered: 07/20/2022 12:10 PM] |
| Filing 4 BRIEFING ORDER filed. Name of Cross-Appeal Appellant for briefing purposes: Therapure Biopharma, Inc. Mailed to: Michael Doornweerd, Michelle Francois, Ryan Hurley, Amit Patel, Laurel Raymond, Andrew Reeve, John Roach, Loreal Rock, Emily Savner, and Previn Warren.. No paper copies required unless case has been tentatively calendared or copies otherwise ordered. For briefing orders issued on or after 7/15/2022, filings must comply with # Appendix Pagination & Brief Citation Guide . [1001195904] Opening Brief and Appendix due 08/29/2022. Opening/Response Brief Due: 09/28/2022. Response/Reply Brief Due 10/28/2022. [22-1722, 22-1763] RJL [Entered: 07/19/2022 10:06 AM] |
|
Filing 3
ORDER filed consolidating case 22-1763 with 22-1722. Cross-appeal appellant: Therapure Biopharma, Inc. Copies to all parties. Mailed to: Michael Doornweerd, Michelle Francois, Ryan Hurley, Amit Patel, Laurel Raymond, Andrew Reeve, John Roach, Loreal Rock, Emily Savner, and Previn Warren. [1001195892] [22-1722, 22-1763] RJL [Entered: 07/19/2022 10:01 AM]
|
| Filing 2 DOCKETING NOTICE issued Re: [ # 1 ] case. Originating case number: 1:19-cv-02092-LKG. Mailed to: Michael Doornweerd, Michelle Francois, Ryan Hurley, Amit Patel, Laurel Raymond, Andrew Reeve, John Roach, Loreal Rock, Emily Savner, and Previn Warren. [1001195882] [22-1763] RJL [Entered: 07/19/2022 09:56 AM] |
| Filing 1 Case docketed. Originating case number: 1:19-cv-02092-LKG. Case manager: RachelLee. [1001195876] [22-1763] RJL [Entered: 07/19/2022 09:53 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
